277 related articles for article (PubMed ID: 25948405)
1. Can variability in the effect of opioids on refractory breathlessness be explained by genetic factors?
Currow DC; Quinn S; Ekstrom M; Kaasa S; Johnson MJ; Somogyi AA; Klepstad P
BMJ Open; 2015 May; 5(5):e006818. PubMed ID: 25948405
[TBL] [Abstract][Full Text] [Related]
2. Repeat dose opioids may be effective for breathlessness in chronic heart failure if given for long enough.
Oxberry SG; Bland JM; Clark AL; Cleland JG; Johnson MJ
J Palliat Med; 2013 Mar; 16(3):250-5. PubMed ID: 23368980
[TBL] [Abstract][Full Text] [Related]
3. Management of refractory breathlessness with morphine in patients with chronic obstructive pulmonary disease.
Smallwood N; Le B; Currow D; Irving L; Philip J
Intern Med J; 2015 Sep; 45(9):898-904. PubMed ID: 26332621
[TBL] [Abstract][Full Text] [Related]
4. Opioids in patients with COPD and refractory dyspnea: literature review and design of a multicenter double blind study of low dosed morphine and fentanyl (MoreFoRCOPD).
van Dijk M; Mooren KJM; van den Berg JK; van Beurden-Moeskops WJC; Heller-Baan R; de Hosson SM; Lam-Wong WY; Peters L; Pool K; Kerstjens HAM
BMC Pulm Med; 2021 Sep; 21(1):289. PubMed ID: 34507574
[TBL] [Abstract][Full Text] [Related]
5. The role of benzodiazepines in breathlessness: a single site, open label pilot of sustained release morphine together with clonazepam.
Allcroft P; Margitanovic V; Greene A; Agar MR; Clark K; Abernethy AP; Currow DC
J Palliat Med; 2013 Jul; 16(7):741-4. PubMed ID: 23597092
[TBL] [Abstract][Full Text] [Related]
6. Patient-Controlled Therapy of Breathlessness in Palliative Care: A New Therapeutic Concept for Opioid Administration?
Schmitz A; Schulz C; Friebel U; Hohlfeld T; Bausewein C
J Pain Symptom Manage; 2016 Mar; 51(3):581-8. PubMed ID: 26578404
[TBL] [Abstract][Full Text] [Related]
7. Influence from genetic variability on opioid use for cancer pain: a European genetic association study of 2294 cancer pain patients.
Klepstad P; Fladvad T; Skorpen F; Bjordal K; Caraceni A; Dale O; Davies A; Kloke M; Lundström S; Maltoni M; Radbruch L; Sabatowski R; Sigurdardottir V; Strasser F; Fayers PM; Kaasa S;
Pain; 2011 May; 152(5):1139-1145. PubMed ID: 21398039
[TBL] [Abstract][Full Text] [Related]
8. Blinded Patient Preference for Morphine Compared to Placebo in the Setting of Chronic Refractory Breathlessness--An Exploratory Study.
Ferreira DH; Silva JP; Quinn S; Abernethy AP; Johnson MJ; Oxberry SG; Currow DC
J Pain Symptom Manage; 2016 Feb; 51(2):247-54. PubMed ID: 26598037
[TBL] [Abstract][Full Text] [Related]
9. The 118 A > G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease.
Klepstad P; Rakvåg TT; Kaasa S; Holthe M; Dale O; Borchgrevink PC; Baar C; Vikan T; Krokan HE; Skorpen F
Acta Anaesthesiol Scand; 2004 Nov; 48(10):1232-9. PubMed ID: 15504181
[TBL] [Abstract][Full Text] [Related]
10. [Validity of recommended minimum dose of prior morphine to initiate transdermal fentanyl patch in prescribing information - multicenter survey of on prescriptions by palliative care specialists in Japan].
Hashizume T; Tomiyasu S; Yomiya K; Yoshimoto T; Harada A; Matoba M;
Gan To Kagaku Ryoho; 2007 Jun; 34(6):897-902. PubMed ID: 17570968
[TBL] [Abstract][Full Text] [Related]
11. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
[TBL] [Abstract][Full Text] [Related]
12. EffenDys-Fentanyl Buccal Tablet for the Relief of Episodic Breathlessness in Patients With Advanced Cancer: A Multicenter, Open-Label, Randomized, Morphine-Controlled, Crossover, Phase II Trial.
Simon ST; Kloke M; Alt-Epping B; Gärtner J; Hellmich M; Hein R; Piel M; Cornely OA; Nauck F; Voltz R
J Pain Symptom Manage; 2016 Nov; 52(5):617-625. PubMed ID: 27693898
[TBL] [Abstract][Full Text] [Related]
13. Prescription of opioids for breathlessness in end-stage COPD: a national population-based study.
Ahmadi Z; Bernelid E; Currow DC; Ekström M
Int J Chron Obstruct Pulmon Dis; 2016; 11():2651-2657. PubMed ID: 27799763
[TBL] [Abstract][Full Text] [Related]
14. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
15. Genetic variation and cognitive dysfunction in opioid-treated patients with cancer.
Kurita GP; Ekholm O; Kaasa S; Klepstad P; Skorpen F; Sjøgren P
Brain Behav; 2016 Jul; 6(7):e00471. PubMed ID: 27247849
[TBL] [Abstract][Full Text] [Related]
16. Opioid switch in palliative care, opioid choice by clinical need and opioid availability.
Müller-Busch HC; Lindena G; Tietze K; Woskanjan S
Eur J Pain; 2005 Oct; 9(5):571-9. PubMed ID: 16139186
[TBL] [Abstract][Full Text] [Related]
17. Regular, sustained-release morphine for chronic breathlessness: a multicentre, double-blind, randomised, placebo-controlled trial.
Currow D; Louw S; McCloud P; Fazekas B; Plummer J; McDonald CF; Agar M; Clark K; McCaffrey N; Ekström MP;
Thorax; 2020 Jan; 75(1):50-56. PubMed ID: 31558624
[TBL] [Abstract][Full Text] [Related]
18. Inhaled nebulized and intranasal opioids for the relief of breathlessness.
Bausewein C; Simon ST
Curr Opin Support Palliat Care; 2014 Sep; 8(3):208-12. PubMed ID: 25004175
[TBL] [Abstract][Full Text] [Related]
19. The Current Practice of Opioid for Cancer Dyspnea: The Result From the Nationwide Survey of Japanese Palliative Care Physicians.
Yamaguchi T; Matsunuma R; Suzuki K; Matsuda Y; Mori M; Watanabe H
J Pain Symptom Manage; 2019 Oct; 58(4):672-677.e2. PubMed ID: 31201876
[TBL] [Abstract][Full Text] [Related]
20. [Parenteral opioids in end-of-life care in cancer patients].
Hattori S; Kimura N; Takatani J; Noguchi T
Gan To Kagaku Ryoho; 2005 Feb; 32(2):161-6. PubMed ID: 15751626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
